Psychemedics Announces First Quarter Results
May 13, 2020 17:15 ET
|
Psychemedics Corporation
ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. The Company’s revenue for...
Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine
May 05, 2020 08:00 ET
|
Psychemedics Corporation
ACTON, Mass., May 05, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced a Vaping Panel to...
Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA
April 29, 2020 12:00 ET
|
Psychemedics Corporation
ACTON, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the first...
Psychemedics Corporation to Webcast 2020 Annual Meeting of Stockholders
April 28, 2020 14:00 ET
|
Psychemedics Corporation
ACTON, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) will hold its Annual Meeting of Stockholders (“Annual Meeting”) on Thursday, May 14, 2020 at 2:00 p.m. ET. The...
Psychemedics Corporation Announces 4th Quarter and Year-End Results
February 11, 2020 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2019. The...
Psychemedics Corporation Responds to Court Decision
October 31, 2019 12:07 ET
|
Psychemedics Corporation
ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department...
Psychemedics Announces Third Quarter Results and Declares 93rd Consecutive Quarterly Dividend
October 22, 2019 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2019. The Company also...
Psychemedics Corporation Announces New Brazilian Distribution Agreement
September 19, 2019 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and...
Psychemedics Announces Second Quarter Results and Declares 92nd Consecutive Quarterly Dividend
July 23, 2019 17:25 ET
|
Psychemedics Corporation
ACTON, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2019. The Company also announced...
Psychemedics Test for Fentanyl Detection Cleared by FDA
April 24, 2019 08:00 ET
|
Psychemedics Corporation
ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...